ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BIAF vs ONMD // OPERATING MARGIN

bioAffinity Technologies Inc. (NASDAQ) VS. OneMedNet Corp (Class A) (NASDAQ) • 15-METRIC TALLY: BIAF 0 — ONMD 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BIAF VS. ONMD) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BIAF ONMD SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — -30.00% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin ACTIVE -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -34.20% 111.40% -145.60 ONMD /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 2/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 34.0 37.7 -3.73 ONMD /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $3.9M $26.3M -$22.4M ONMD /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BIAF REV ONMD REV BIAF GROSS % ONMD GROSS % BIAF FCF ONMD FCF
FY 2025 $6.2M $1.4M — -37.0% -$9.4M -$7.5M
FY 2024 $9.4M $643.0K — -43.7% -$7.3M -$7.0M
FY 2023 $2.5M $1.0M — — -$6.0M -$4.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BIAF // BETA —
ONMD // BETA —